Copper-Catalyzed Domino Synthesis of 4-OxopyrimidoACTHNUGRTNEUNG[1,2-a]indole Derivatives
solid; mp >2508C; 1H NMR (DMSO-d6, 300 MHz): d=
13.13 (s, 1H), 8.77 (s, 1H), 7.69–7.65 (m, 2H), 5.77 (s, 1H),
2.34 (s, 3H); 13C NMR (DMSO-d6, 75 MHz): d=158.9,
152.8, 145.6, 130.9, 127.9, 125.3 (q, J=271.7 Hz) 122.5 (q, J=
31.8 Hz), 122.1, 118.0, 114.6, 113.3, 98.6, 66.7, 19.2; ESI-MS:
m/z=291.3 [M+H]+.
Experimental Section
General Procedure for the Synthesis of Compounds
3a–t using 1a–g as the Substrates
A 25-mL Schlenk tube was charged with a magnetic stirrer
and DMSO (2.0 mL). CuI (0.025 mmol, 4.8 mg), pipecolic
acid (0.05 mmol, 6.4 mg), K2CO3 (0.75 mmol, 104 mg), N-(2-
halophenyl)-3-oxoalkanamide (1) (0.25 mmol), and substi-
tuted nitrile (2) (0.375 mmol) were added to the tube. The
reaction was performed at 90 or 1108C for 24 h under a ni-
trogen atmosphere in the sealed tube (see Table 2 for de-
tails). After being cooled to room temperature, the mixture
was poured into 10 mL of water, and the resulting solution
was extracted with ethyl acetate (3ꢂ10 mL). The combined
organic layer was concentrated, and the residue was purified
by flash chromatography on silica gel (eluent: petroleum
ether/ethyl acetate=5:1 to 1:1) to afford the target products
3a–t.
Acknowledgements
The authors wish to thank the National Natural Science
Foundation of China (Grant Nos. 21172128 and 21221062),
and the Ministry of Science and Technology of China (Grant
No. 2012CB722605) for financial support.
References
[1] a) P. J. Crowley, in: Comprehensive Heterocyclic
Chemistry, (Eds.: A. R. Katritzky, C. W. Rees), Perga-
mon, New York, 1984; b) J. K. Landquist, in: Compre-
hensive Heterocyclic Chemistry, (Eds.: A. R. Katritzky,
C. W. Rees), Pergamon, New York, 1984.
[2] For reviews, see a) K. Undheim, T. Benneche, in: Com-
prehensive Heterocyclic Chemistry II, (Eds.: A. R. Ka-
tritzky, C. W. Rees, E. F. V. Scriven, A. McKillop), Per-
gamon: Oxford, 1996, Vol. 6, p 93; b) J. A. Joule, K.
Mills, in: Heterocyclic Chemistry, 4th edn.; Blackwell
Science Ltd., Cambridge MA, 2000, p 194; c) A. W.
Erian, Chem. Rev. 1993, 93, 1991; d) J. P. Michael, Nat.
Prod. Rep. 2005, 22, 627; e) I. M. Lagoja, Chem. Biodi-
versity 2005, 2, 1.
[3] a) M. Markowitz, J. Q. Morales-Ramirez, B. Y. Nguyen,
C. M. Kovacs, R. T. Steigbigel, D. A. Cooper, R. Lipor-
ace, R. Schwartz, R. Isaacs, L. R. Gilde, L. Penning, J.
Zhao, H. Teppler, J. Acquir. Immune Def. Syndr. 2006,
43, 509; b) D. J. Hazuda, P. Felock, M. Witmer, A.
Wolfe, K. Stillmock, J. A. Grobler, A. Espeseth, L.
Gabryelski, W. Schleif, C. Blau, M. D. Miller, Science
2000, 287, 646; c) D. J. Hazuda, S. D. Young, J. P.
Guare, N. J. Anthony, R. P. Gomez, J. S. Wai, J. P.
Vacca, L. Handt, S. L. Motzel, H. J. Klein, G. Dornadu-
la, R. M. Danovich, M. V. Witmer, K. A. Wilson, L.
Tussey, W. A. Schleif, L. S. Gabryelski, L. Jin, M. D.
Miller, D. R. Casimiro, E. A. Emini, J. W. Shiver, Sci-
ence 2004, 305, 528; d) E. Muraglia, O. Kinzel, C. Gar-
delli, B. Crescenzi, M. Donghi, M. Ferrara, E. Nizi, F.
Orvieto, G. Pescatore, R. Laufer, O. Gonzalez-Paz,
A. D. Marco, F. Fiore, E. Monteagudo, M. Fonsi, P. J.
Felock, M. Rowley, V. Summa, J. Med. Chem. 2008, 51,
861.
General Procedure for the Synthesis of Compounds
3b, 3e, 3u and 3v using 1h and 1i as the Substrates
A 25-mL Schlenk tube was charged with a magnetic stirrer
and DMSO (2.0 mL). CuI (0.05 mmol, 9.6 mg), pipecolic
acid (0.10 mmol, 12.8 mg), Cs2CO3 (1 mmol, 326 mg), N-(2-
halophenyl)-3-oxoalkanamide (1) (0.5 mmol), and substitut-
ed nitrile (2) (0. 75 mmol) were added to the tube. The reac-
tion was performed at 1108C for 24 h under a nitrogen at-
mosphere in the sealed tube (see Table 2 for details). After
being cooled to room temperature, the mixture was poured
into 10 mL of water, and the resulting solution was extracted
with ethyl acetate (3ꢂ10 mL). The combined organic layer
was concentrated, and the residue was purified by flash
chromatography on silica gel (eluent: petroleum ether/ethyl
acetate=5:1 to 1:1) to afford the target products 3b, 3e, 3u
and 3v). Three representative examples are presented
below.
Butyl 2-methyl-4-oxo-1,4-dihydropyrimidoACTHUNRTGNEUNG[1,2-a]indole-
10-carboxylate (3c): Eluent: petroleum ether/ethyl acetate
1
(3:1); yield: 54 mg (73%); colorless oil; H NMR (CDCl3,
300 MHz): d=10.01 (s, 1H), 8.64 (d, 1H, J=8.3 Hz), 7.92
(d, 1H, J=7.9 Hz), 7.41 (t, 1H, J=7.2 Hz), 7.29 (t, 1H, J=
7.2 Hz), 5.66 (s, 1H), 4.38 (t, 2H, J=6.5 Hz), 2.34 (s, 3H),
1.88–1.78 (m, 2H), 1.61–1.49 (m, 2H), 1.02 (t, 3H, J=
7.4 Hz); 13C NMR (CDCl3, 75 MHz): d=166.9, 159.4, 148.3,
143.5, 129.9, 125.7, 125.4, 122.3, 119.5, 116.3, 99.2, 87.8, 64.2,
31.1, 19.7, 19.5, 13.9; ESI-MS: m/z=299.6 [M+H]+.
Butyl 8-bromo-2-methyl-4-oxo-1,4-dihydropyrimidoACHTUNTRGNEUNG[1,2-
a]indole-10-carboxylate (3s): Eluent: petroleum ether/ethyl
acetate (5:1 to 3:1); yield: 58 mg (62%); white solid; mp
187–1898C; 1H NMR (CDCl3, 300 MHz): d=9.99 (s, 1H),
8.49 (d, 1H, J=8.6 Hz), 8.01 (d, 1H, J=1.4 Hz), 7.37 (dt,
1H, J=8.8 Hz, J=1.9 Hz), 5.70 (s, 1H), 4.39 (t, 2H, J=
6.71 Hz), 2.39 (s, 3H), 1.89–1.79 (m, 2H), 1.61–1.48 (m, 2H),
1.04 (t, 3H, J=7.4 Hz); 13C NMR (CDCl3, 75 MHz): d=
166.4, 158.9, 148.6, 143.9, 128.5, 127.4, 125.2, 122.3, 119.2,
117.6, 99.5, 87.4, 64.4, 31.1, 19.9, 19.5, 13.9; ESI-MS: m/z=
379.0 [M+H]+.
[4] J. Ishida, K. Hattori, H. Yamamoto, A. Iwashita, K. Mi-
harab, N. Matsuoka, Bioorg. Med. Chem. Lett. 2005, 15,
4221.
[5] M. G. Nair, R. Dhawan, M. Ghazala, T. I. Kalman, R.
Ferone, Y. Gaumont, R. L. Kisliuk, J. Med. Chem.
1987, 30, 1256.
[6] B. Krçnig, D. B. Pittrow, W. Kirch, D. Welzel, G. Wei-
2-Methyl-4-oxo-7-(trifluoromethyl)-1,4-dihydropyrimido-
dinger, Hypertension 1997, 29, 651.
[7] J. G. Hurdle, A. J. OꢀNeill, I. Chopra, J. Antimicrob.
Chemother. 2004, 54, 549.
N
Adv. Synth. Catal. 0000, 000, 0 – 0
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7
ÞÞ
These are not the final page numbers!